{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:31:46Z","timestamp":1784871106145,"version":"3.55.0"},"reference-count":37,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute, NCI","doi-asserted-by":"publisher","award":["U2CCA252971"],"award-info":[{"award-number":["U2CCA252971"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute, NCI","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute, NCI","doi-asserted-by":"publisher","award":["U54 CA285116"],"award-info":[{"award-number":["U54 CA285116"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The incidence of early-onset colorectal cancer (EOCRC; &lt;50 years) continues to increase, with the most rapid rises occurring among Hispanic\/Latino (H\/L) populations who remain underrepresented in molecular research. Because the TP53 signaling pathway is a key driver of colorectal tumorigenesis, this study aimed to clarify its prognostic significance in FOLFOX-treated EOCRC across ancestry groups. We analyzed 2515 colorectal cancer (CRC) cases (266 H\/L, 2249 non-Hispanic White [NHW]) stratified by ancestry, age at onset, and FOLFOX exposure. Fisher\u2019s exact, chi-square, and Kaplan\u2013Meier\u2019s analyses were applied, and multi-dimensional data integration was performed using AI-HOPE and AI-HOPE-TP53, conversational artificial intelligence platforms enabling natural language-driven exploration of clinical, genomic, and therapeutic features. TP53 pathway alterations were common in both H\/L (85%) and NHW (83%) FOLFOX-treated patients. Among late-onset NHW cases, FOLFOX treatment was associated with higher TP53 mutation frequencies and lower ATM and CDKN2A mutation rates compared with untreated counterparts, while CHEK2 alterations were significantly less frequent in late-onset H\/L patients. Missense mutations were the predominant alteration type across groups. These findings suggest that TP53 pathway alterations may be associated with ancestry- and treatment-specific clinical patterns in EOCRC and illustrate how AI-enabled integrative analytic frameworks can facilitate hypothesis generation and prioritize candidate biomarkers for future validation in precision oncology.<\/jats:p>","DOI":"10.3390\/ijms27031607","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:33:50Z","timestamp":1770384830000},"page":"1607","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial Intelligence-Enabled Integration Suggests TP53 Pathway Alterations as Prognostic Biomarkers in Populations with Disproportionate Health Burdens"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-1526","authenticated-orcid":false,"given":"Fernando C.","family":"Diaz","sequence":"first","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5991-9779","authenticated-orcid":false,"given":"Brigette","family":"Waldrup","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-4197","authenticated-orcid":false,"given":"Francisco G.","family":"Carranza","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0607-1784","authenticated-orcid":false,"given":"Sophia","family":"Manjarrez","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-6414","authenticated-orcid":false,"given":"Enrique","family":"Velazquez-Villarreal","sequence":"additional","affiliation":[{"name":"Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA"},{"name":"City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"ref_1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","article-title":"The rising tide of early-onset colorectal cancer: A comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection","volume":"7","author":"Patel","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102821","DOI":"10.1016\/j.ctrv.2024.102821","article-title":"Early-Onset colorectal Cancer: From the laboratory to the clinic","volume":"130","author":"Gandini","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1878-0261.12417","article-title":"Early-onset colorectal cancer in young individuals","volume":"13","author":"Mauri","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2320035","DOI":"10.1001\/jamanetworkopen.2023.20035","article-title":"Association of Age With Treatment-Related Adverse Events and Survival in Patients with Metastatic Colorectal Cancer","volume":"6","author":"Meng","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Muller, C., Ihionkhan, E., Stoffel, E.M., and Kupfer, S.S. (2021). Disparities in Early-Onset Colorectal Cancer. Cells, 10.","DOI":"10.3390\/cells10051018"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated Projection of US Cancer Incidence and Death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jnci\/djae288","article-title":"Trends in cancer mortality under age 50 in 15 upper-middle and high-income countries","volume":"117","author":"Santucci","year":"2025","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMra2200869","article-title":"Increasing Incidence of Early-Onset Colorectal Cancer","volume":"386","author":"Sinicrope","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jim-2016-000229","article-title":"Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: A SEER-based analysis with comparison to other young-onset cancers","volume":"65","author":"Bhandari","year":"2017","journal-title":"J. Investig. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2400393","DOI":"10.1200\/GO-24-00393","article-title":"Immigrant Health and Early-Onset Colorectal Cancer Disparities: Results From the Spanish Early-Onset Colorectal Cancer Consortium","volume":"10","author":"Perea","year":"2024","journal-title":"JCO Glob Oncol."},{"key":"ref_12","unstructured":"Hamilton, D.M., Hayes-Bautista, D., and Hsu, P. (2025). 2025 U.S. Latino GDP Report [Internet], The Latino GDP Project, Community Partners. Available online: https:\/\/blogs.callutheran.edu\/cerf\/files\/2025\/04\/2025_USLatinoGDP_FINAL.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/1354750X.2024.2447089","article-title":"Mutational and co-mutational landscape of early onset colorectal cancer","volume":"30","author":"Alshenaifi","year":"2025","journal-title":"Biomarkers"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Antelo, M., Balaguer, F., Shia, J., Shen, Y., Hur, K., Moreira, L., Cuatrecasas, M., Bujanda, L., Giraldez, M.D., and Takahashi, M. (2012). A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045357"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-19-0899","article-title":"Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer","volume":"25","author":"Lieu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Storandt, M.H., Shi, Q., Eng, C., Lieu, C., George, T., Stoppler, M.C., Mauer, E., Yilma, B., Fragkogianni, S., and Teslow, E.A. (2025). Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations. Cancers, 17.","DOI":"10.3390\/cancers17050836"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1097\/JS9.0000000000001584","article-title":"Molecular characteristics of early-onset compared with late-onset colorectal cancer: A case controlled study","volume":"110","author":"Tang","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1007\/s40615-024-02178-8","article-title":"Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United States","volume":"12","author":"Figueroa","year":"2024","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e6814","DOI":"10.1002\/cam4.6814","article-title":"Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20\u2009years","volume":"13","author":"Monge","year":"2024","journal-title":"Cancer Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41416-020-01038-6","article-title":"Cancer health disparities in racial\/ethnic minorities in the United States","volume":"124","author":"Zavala","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Monge, C., Waldrup, B., Carranza, F.G., and Velazquez-Villarreal, E. (2024). WNT and TGF-Beta Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic\/Latino Populations. Cancers, 16.","DOI":"10.1101\/2024.10.17.24315250"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Monge, C., Waldrup, B., Carranza, F.G., and Velazquez-Villarreal, E. (2025). Ethnicity-Specific Molecular Alterations in MAPK and JAK\/STAT Pathways in Early-Onset Colorectal Cancer. Cancers, 17.","DOI":"10.1101\/2025.02.17.25322443"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70791","DOI":"10.1002\/cam4.70791","article-title":"Detecting PI3K and TP53 Pathway Disruptions in Early-Onset Colorectal Cancer Among Hispanic\/Latino Patients","volume":"14","author":"Monge","year":"2025","journal-title":"Cancer Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: All mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly, M., Linehan, A., Krstic, A., Kolch, W., Sheahan, K., Winter, D.C., and Mc Dermott, R. (2023). Oncotherapeutic Strategies in Early Onset Colorectal Cancer. Cancers, 15.","DOI":"10.3390\/cancers15020552"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: Mechanisms, structures, and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of Metastatic Colorectal Cancer: ASCO Guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjc.6605239","article-title":"Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer","volume":"101","author":"Chua","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41416-019-0429-2","article-title":"p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy","volume":"120","author":"Oh","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1200\/JCO.2005.00.471","article-title":"TP53-CRC Collaborative Study Group. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: Influence of tumor site, type of mutation, and adjuvant treatment","volume":"23","author":"Russo","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"btaf359","DOI":"10.1093\/bioinformatics\/btaf359","article-title":"AI-HOPE: An AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research","volume":"41","author":"Yang","year":"2025","journal-title":"Bioinformatics"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yang, E.W., Waldrup, B., and Velazquez-Villarreal, E. (2025). AI-HOPE-TP53: A Conversational Artificial Intelligence Agent for Pathway-Centric Analysis of TP53-Driven Molecular Alterations in Early-Onset Colorectal Cancer. Cancers, 17.","DOI":"10.1101\/2025.05.23.25328251"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Diaz, F.C., Waldrup, B., Carranza, F.G., Manjarrez, S., and Velazquez-Villarreal, E. (2025). Precision Oncology Insights into WNT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer in High-Risk Populations. Cancers, 17.","DOI":"10.1101\/2025.08.02.25332877"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Diaz, F.C., Waldrup, B., Carranza, F.G., Manjarrez, S., and Velazquez-Villarreal, E. (2025). Artificial Intelligence-Enhanced Precision Medicine Reveals Prognostic Impact of TGF-Beta Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer Among Disproportionately Affected Populations. Int. J. Mol. Sci., 26.","DOI":"10.1101\/2025.08.11.25333363"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Diaz, F.C., Waldrup, B., Carranza, F.G., Manjarrez, S., and Velazquez-Villarreal, E. (2025). Artificial Intelligence-Guided Molecular Determinants of PI3K Pathway Alterations in Early-Onset Colorectal Cancer Among High-Risk Groups Receiving FOLFOX. Biomedicines, 13.","DOI":"10.1101\/2025.08.18.25333929"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e76553","DOI":"10.2196\/76553","article-title":"Conversational Artificial Intelligence for Integrating Social Determinants, Genomics, and Clinical Data in Precision Medicine: Development and Implementation Study of the AI-HOPE-PM System","volume":"6","author":"Yang","year":"2025","journal-title":"JMIR Bioinform. Biotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Carranza, F.G., Diaz, F.C., Ninova, M., and Velazquez-Villarreal, E. (2024). Current state and future prospects of spatial biology in colorectal cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1513821"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1607\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:35:45Z","timestamp":1770384945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27031607"],"URL":"https:\/\/doi.org\/10.3390\/ijms27031607","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}